GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

American Express AXP · USD

Financials · Consumer Finance · US listing · 🇺🇸 United States

S&P 500Dow Jones

Compare

324.31

+1.03%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

35 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 14Buy
  • 16Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 324.31Average target 378.09

Low
315.00
Average
378.09
Median
384.00
High
415.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$79.44bn$86.64bn$94.05bn$103.98bn$76.42bn
Revenue, highest$79.66bn$87.18bn$95.73bn$104.83bn$77.05bn
Revenue, lowest$79.26bn$85.54bn$91.48bn$102.54bn$75.37bn
Earnings per share18.2520.1723.2027.4528.70
Earnings per share, highest18.6220.4624.4227.7429.01
Earnings per share, lowest18.0519.9121.1426.9528.18
Analysts181817138

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast4.534.454.063.574.043.933.503.07
Reported4.684.534.283.534.144.083.643.04
Difference+3.3%+1.8%+5.3%-1.2%+2.6%+3.9%+4.1%-0.9%

Rating changes

Latest broker notes

  • Piper SandlerOverweight
  • UBSNeutral
  • Morgan StanleyEqual Weight
  • Evercore ISI GroupIn Line
  • BTIGSell
  • JP MorganNeutral → Overweight
  • HSBCHold
  • B of A SecuritiesBuy
  • UBSNeutral
  • TD CowenHold
  • BarclaysEqual Weight
  • Evercore ISI GroupIn Line

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 8.9% a year over 10 years. Return on equity 32.4%.

Model fair value

323.24

From earnings 323.24, from revenue 293.15.

Piotroski score

7 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.